113 related articles for article (PubMed ID: 28439968)
1. Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys.
Matsuya H; Sekido N; Kida J; Mashimo H; Wakamatsu D; Okada H
Low Urin Tract Symptoms; 2018 May; 10(2):204-211. PubMed ID: 28439968
[TBL] [Abstract][Full Text] [Related]
2. Promising Effects of a Novel EP2 and EP3 Receptor Dual Agonist, ONO-8055, on Neurogenic Underactive Bladder in a Rat Lumbar Canal Stenosis Model.
Sekido N; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
J Urol; 2016 Aug; 196(2):609-16. PubMed ID: 26880410
[TBL] [Abstract][Full Text] [Related]
3. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Sekido N; Otsuki T; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of a novel EP2 and EP3 receptor dual agonist, ONO-8055, on lower urinary tract function in normal and lumbar canal stenosis rats.
Sekido N; Kida J; Otsuki T; Mashimo H; Matsuya H; Okada H
Low Urin Tract Symptoms; 2020 Jan; 12(1):99-106. PubMed ID: 31430051
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a potent, well-balanced EP
Kinoshita A; Higashino M; Yoshida K; Aratani Y; Kakuuchi A; Hanada K; Takeda H; Naganawa A; Matsuya H; Ohmoto K
Bioorg Med Chem; 2018 Jan; 26(1):200-214. PubMed ID: 29203142
[TBL] [Abstract][Full Text] [Related]
6. IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
Yamane S; Karakawa T; Nakayama S; Nagai K; Moriyuki K; Neki S; Suto F; Kambe T; Hirota Y; Kawabata K
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2547-52. PubMed ID: 25788650
[TBL] [Abstract][Full Text] [Related]
7. A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model.
Sekido N; Jyoraku A; Okada H; Wakamatsu D; Matsuya H; Nishiyama H
Neurourol Urodyn; 2012 Sep; 31(7):1190-6. PubMed ID: 22473471
[TBL] [Abstract][Full Text] [Related]
8. Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
Sekido N; Kida J; Wakamatsu D; Okada H; Matsuya H
Urology; 2014 Nov; 84(5):1248.e9-15. PubMed ID: 25443946
[TBL] [Abstract][Full Text] [Related]
9. Characterization of voiding function and structural bladder changes in a rat model of neurogenic underactive bladder disease.
Weyne E; Dewulf K; Deruyer Y; Rietjens R; Everaerts W; Bivalacqua TJ; De Ridder D; Van der Aa F; Albersen M
Neurourol Urodyn; 2018 Jun; 37(5):1594-1604. PubMed ID: 30105760
[TBL] [Abstract][Full Text] [Related]
10. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of the Long-lasting Potentiating Effect of Distigmine on Urinary Bladder Motility].
Obara K; Tanaka Y
Yakugaku Zasshi; 2021; 141(2):245-254. PubMed ID: 33518645
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
14. EP2 receptor plays pivotal roles in generating mechanical hyperalgesia after lengthening contractions.
Ota H; Katanosaka K; Murase S; Furuyashiki T; Narumiya S; Mizumura K
Scand J Med Sci Sports; 2018 Mar; 28(3):826-833. PubMed ID: 28759126
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
16. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
Nilsson SF; Drecoll E; Lütjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
Kobayashi K; Murata T; Hori M; Ozaki H
Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
[TBL] [Abstract][Full Text] [Related]
18. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Tada M; Fujita N; Umeda M; Koike H; Nagai H
No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
[TBL] [Abstract][Full Text] [Related]
19. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatments available for the management of underactive bladder in neurological conditions.
Ladi-Seyedian SS; Nabavizadeh B; Sharifi-Rad L; Kajbafzadeh AM
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):193-204. PubMed ID: 29202586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
